Fig. 2 | Scientific Reports

Fig. 2

From: Tyrosine phosphatase SHP2 accelerated ovarian cancer via modulating integrin/ E-Cadherin/ ZEB1 induced EMT

Fig. 2

The EGF/SHP2/ZEB1 signaling pathway is activated and E-Cadherin is abnormally low in human ovarian cancer tissues. (A) Western blot analysis of the protein bands of EGF, p-SHP2, ZEB1 and E-Cadherin; (B) Statistical analysis of the relative protein expression levels of EGF, p-SHP2, ZEB1 and E-Cadherin. GAPDH was used as a control protein. Data are expressed as mean ± standard deviation. N = 30, P < 0.05 is considered statistically significant. **P < 0.01.

Back to article page